Navigation Links
Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
Date:8/30/2011

filled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.  For more information on Unilife, please visit www.unilife.com.

Notes:

(1) MarketsandMarkets. Global Injectable Drug Delivery Market. 2010-2015.

Forward-Looking StatementsThis press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission.


'/>"/>

SOURCE Unilife Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
2. Unilife Signs $10 Million Equipment Financing Agreement
3. Unilife Expands Management Team to Support Business Growth
4. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
5. Unilife Successfully Completes Industrialization of Unifill Syringe
6. Unilife Hosts White House Business Council Meeting
7. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
8. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
9. Unilife Announces Financial Results for the Third Quarter of Fiscal 2011
10. Unilife Corporation to Announce Financial Results for Fiscal 2011 Third Quarter on Monday, May 16, 2011
11. Unilife to Present at the 36th Annual Deutsche Bank Health Care Conference on Monday, May 2, 2011 in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... that address unmet medical needs in the areas ... has completed enrollment of the additional subjects, as ... this year, into the company,s Phase 2 study ... regulator (IDR) and is being evaluated as a ...
(Date:8/31/2015)... August 31, 2015 Premune ... into an exclusive licensing agreement for Redonyl ® ... $300 million USD veterinary dermatology market, is a nutritional ... support healthy skin in dogs and cats. Redonyl ® ... , and has been received positively in the ...
(Date:8/31/2015)... Aug. 31, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of diseases of ... that its BNC101 IND submission has passed review by ... to initiate a Phase 1 clinical trial in patients ... pancreatic cancer prior to 31 December 2015. ...
Breaking Medicine Technology:Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4
... ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and ... it will participate in the 2009 Canaccord Adams Cardiovascular ... Dale, President and CEO of ATS Medical, will present ... 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , Attendance at ...
... 3 Robert Mazzacavallo has joined Veridiam as the ... contract manufacturer of high-precision, fabricated assemblies and metal components, ... power generation, aerospace and general industrial markets. , Before ... Industries in Camas, WA. At C-Tech, Bob worked ...
Cached Medicine Technology:ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference 2Veridiam Names Robert Mazzacavallo New CFO 2
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... Patients ... from and those who are interested in learning more about the procedure beyond the ... Mohebi. , Internationally recognized hair transplant surgeon Parsa Mohebi will be on hand ...
(Date:8/31/2015)... ... 31, 2015 , ... The Sundance Film Festival award winning documentary “Alive Inside” ... Inside” shadows a social worker who advocates for the use of music therapy for ... music to residents in health care centers who may have lost a spark in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Garden ... in 2008, the result of a merger of five of the busiest urology ... they could provide more cost-effective and higher quality care than they did individually. ...
(Date:8/31/2015)... ... 2015 , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed ... Dr. Michael Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. ... both sports in his senior year. He was inducted into the National Honor Society ...
(Date:8/31/2015)... TN (PRWEB) , ... August 31, 2015 , ... ... how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination ... the most common cause of visual impairment among children, affecting approximately 2 to 3 ...
Breaking Medicine News(10 mins):Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3
... Serena Gordon HealthDay Reporter , THURSDAY, Jan. 13 ... SAT that,s got your teen,s stomach tied up in knots, ... scores. New research, published in the Jan. 14 issue ... minutes writing about their test anxiety and fears just before ...
... Drugs that pharmaceutical companies market most aggressively to physicians and ... most patients a phenomenon described as the "inverse benefit ... Branch at Galveston. Published online Thursday, Jan. 13 ... article explores recent withdrawals of blockbuster drugs due to safety ...
... (MGH) Cancer Center researchers have discovered a previously unknown feature ... sequences that do not code for proteins. These DNA ... their role in chromosomal structure but previously were not suspected ... appear in the journal Science and is receiving ...
... , THURSDAY, Jan. 13 (HealthDay News) -- In an unscripted ... Tucson and America" memorial, President Barack Obama said Rep. Gabrielle ... and her husband Mark Kelly at University Medical Center in ... to House Minority Leader Nancy Pelosi (D-Calif.) confirmed that Pelosi, ...
... and reconstructed the genomes of most of the ... and documented how the microbe populations changed over ... eventually help researchers understand the causes of various ... sometimes fatal necrotizing enterocolitis, according to researchers at ...
... programs that put them behind the wheelin a driving simulator, ... the conclusion of a new article published in Current ... for Psychological Science. Older people are at much ... and provinces test older drivers, hoping to get the riskiest ...
Cached Medicine News:Health News:Write Your Test Stress Away 2Health News:Write Your Test Stress Away 3Health News:Inverse benefits due to drug marketing undermine patient safety and public health 2Health News:Inverse benefits due to drug marketing undermine patient safety and public health 3Health News:Overexpression of repetitive DNA sequences discovered in common tumor cells 2Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 2Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 3Health News:Scientists sequence gut microbes of premature infant 2Health News:Scientists sequence gut microbes of premature infant 3Health News:Scientists sequence gut microbes of premature infant 4Health News:Scientists sequence gut microbes of premature infant 5Health News:Driving simulators help older adults improve their road skills 2
... Artemis is the world's first very high ... 3D Arc-scanning technology, Artemis provides microscopic resolution ... cornea and anterior segments of the human ... (VHF) ultrasound eye scanner. In use, the ...
The UD-6000 combines all the functions of modern ultrasound diagnostics used in ophthalmology: The latest generation high resolution A/B-sector scanner, a diagnostic A-mode scanner with an optional p...
... is a sensitive B-scan system which quickly identifies ... of both eyes differ by more than 0.3 ... be suspected. The B5500 enables quick and easy ... water bath or inserting shells under the lids. ...
... CineScan A/B represent a true breakthrough in ... with technology and diagnostic capability previously unavailable. ... vitreous. Adjust the gain up to 105db ... invisible at a standard 90db setting - ...
Medicine Products: